Principal Investigator & Cardiometabolic Research Lead

Pablo Mora, MD, FACE, MSc, CDCES

Board-Certified Endocrinologist

Pablo F. Mora, MD, FACE, MSc, CDCES, is a board-certified endocrinologist, diabetes educator, clinical professor, and Principal Investigator with 30+ years of cardiometabolic experience and experience conducting 30+ clinical trials. His work in type 1 diabetes, modern insulin delivery, diabetes technology, and metabolic disease gives Sponsors and CROs deep endocrine expertise.

Dr. Mora practices at North Texas Diabetes and Endocrinology and serves as Clinical Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism at UT Southwestern Medical Center.

Recent Publications

  • Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial (Read this in The Lancet)
  • Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial (Read this in The Lancet)

"The exciting world of metabolic and hormonal diseases is full of opportunities for new pharmacologic and technological interventions to improve health and quality of life. The last 25 years of active diabetes research have brought major advances in managing chronic conditions, and that progress continues."

Pablo Mora, MD, FACE, MSc, CDCES

Research Site(s)

30+
years in practice

30+
trials conducted

Capabilites & Expertise

Qualifications

  • Board-certified endocrinologist and diabetes, metabolism, and endocrinology key opinion leader
  • 30+ years of cardiometabolic care experience and experience conducting 30+ clinical trials
  • Practicing endocrinologist at North Texas Diabetes and Endocrinology
  • Certified Diabetes Care and Education Specialist
  • Clinical Professor at UT Southwestern Medical Center, Division of Endocrinology
  • Specializes in type 1 diabetes, modern insulin delivery methods, and technology-supported therapeutic decisions
  • Recipient of the Daniel Foster Award for Clinical Teaching from the Division of Endocrinology at UT Southwestern Medical Center

Education

  • Medical school: University of Costa Rica School of Medicine
  • Residency: University Hospitals in San Jose, Costa Rica, internal medicine
  • Fellowship: University Hospitals in San Jose, Costa Rica, critical care; UT Southwestern Medical Center, endocrinology and metabolism
  • Master's degree: Clinical sciences/clinical research, UTSW Allied Health School

Location(s)

Therapeutic Experience

  • Chronic kidney disease
  • Type 1 and type 2 diabetes
  • Graves disease
  • Hyperthyroidism and hypothyroidism
  • Hypertension
  • MASH/NASH
  • Obesity
  • Diabetic peripheral neuropathy
  • Thyroid eye disease

Get to Know Pablo Mora, MD, FACE, MSc, CDCES

Pablo Mora, MD, FACE, MSc, CDCES

Pablo F. Mora, MD, FACE, MSc, CDCES, is a board-certified endocrinologist, Certified Diabetes Care and Education Specialist, clinical professor, and Principal Investigator with 30+ years of cardiometabolic experience and experience conducting 30+ clinical trials. He practices at North Texas Diabetes and Endocrinology in Plano, Texas, and serves as Clinical Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism at UT Southwestern Medical Center.

Dr. Mora earned his undergraduate degree and medical degree from the University of Costa Rica School of Medicine. He completed internal medicine residency and critical care fellowship training at the University Hospitals in San Jose, Costa Rica, followed by fellowship training in endocrinology and metabolism at UT Southwestern Medical Center. He also earned a master’s degree in clinical sciences with a clinical research focus from UTSW Allied Health School.

Dr. Mora’s clinical interests include transitional programs for individuals with type 1 diabetes, modern insulin delivery systems, diabetes technology, and clinical research of new pharmacologic interventions for type 1 diabetes, type 2 diabetes, and nonalcoholic fatty liver disease.

He has received several awards, including the Daniel Foster Award for Clinical Teaching from the Division of Endocrinology at UT Southwestern Medical Center. His combination of clinical teaching, endocrine subspecialty care, diabetes education, and clinical research makes him a strong partner for complex metabolic studies.

Submit Your Information